![BMS-599626 Catalog No.:M10781-10 ¹⁶]octadec-4-ene-4-carbonitrile](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10781_1621562460.gif?v=1621562462)
Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
¹⁶]octadec-4-ene-4-carbonitrile
Mavoglurant exerts its effect as an antagonist of the metabotropic glutamate receptor 5 (mGLU5)
Formula: C18H18N4O3S
It was also approved by the FDA in January 2015 for the prevention of stroke and non–central-nervous-system systemic embolism
5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5
BMS-599626 Catalog No.:M10781-10 ¹⁶]octadec-4-ene-4-carbonitrileAC480, also known as BMS 599626, is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50 =22, 32 and 190 nM, respectively) with potential antineoplastic activity. BMS 599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. Product information CAS Number: 714971 09 2 Molecular Weight: 530. 55 Formula:
US$ 129.00
US$ 29.00
US$ 135.00
US$ 135.00
US$ 129.00
US$ 499.50
US$ 129.00
US$ 135.00
US$ 110.00
US$ 110.00
US$ 424.50
US$ 424.50
US$ 10.00
US$ 40.00
US$ 424.50